XML 80 R24.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock-Based Compensation (Details) (USD $)
3 Months Ended 6 Months Ended
Jul. 28, 2012
Jul. 30, 2011
Jul. 28, 2012
Jul. 30, 2011
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total compensation expense $ 2,111,000 $ 2,297,000 $ 3,436,000 $ 4,079,000
Related tax benefit (794,000) (853,000) (1,292,000) (1,521,000)
Compensation expense, net of tax 1,317,000 1,444,000 2,144,000 2,558,000
Unrecognized compensation cost 18,700,000   18,700,000  
Unrecognized compensation cost, period for recognition (in years)     2 years 8 months 12 days  
Stock Options and SARs [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total compensation expense 673,000 1,097,000 1,540,000 2,123,000
Significant weighted average assumptions [Abstract]        
Expected volatility, minimum (in hundredths)       63.40%
Expected volatility, maximum (in hundredths)       63.70%
Weighted average volatility (in hundredths)       63.60%
Risk-free rate, minimum (in hundredths)       1.50%
Risk-free rate, maximum (in hundredths)       1.90%
Expected life (in years)       4 years 3 months 18 days
Stock Options and SARs [Abstract]        
Award vesting period (in years)     4 years  
Percentage of awards vesting each year (in hundredths)     25.00%  
Award vesting rights     End of each of the first four years following the date of grant  
Award expiration period (in years)     7Y  
Weighted average grant date fair value   $ 8.69   $ 8.69
Share Based Compensation Stock Options and SARs Outstanding [Roll Forward]        
Beginning Balance (in shares)     4,004,257  
Exercised (in shares)     (641,170)  
Forfeited (in shares)     (625,562)  
Ending Balance (in shares) 2,737,525   2,737,525  
Vested or expected to vest (in shares) 2,565,322   2,565,322  
Exercisable (in shares) 1,876,511   1,876,511  
Stock Options and SARs, Weighted Average Exercise Price [Abstract]        
Beginning Balance (in dollars per share)     $ 16.10  
Exercised (in dollars per share) $ 12.24   $ 12.24  
Forfeited (in dollars per share) $ 16.70   $ 16.70  
Ending Balance (in dollars per share) $ 16.87   $ 16.87  
Vested or expected to vest (in dollars per share) $ 16.93   $ 16.93  
Exercisable (in dollars per share) $ 17.28   $ 17.28  
Stock Options and SARs, Weighted Average Remaining Contractual Term (years) [Abstract]        
Ending Balance (in years) 3.2   3.2  
Vested And Expected To Vest (in years) 3.1   3.1  
Exercisable (in years) 2.4   2.4  
Stock Options and SARs, Aggregate Intrinsic Value [Abstract]        
Ending Balance 6,779,000   6,779,000  
Vested And Expected To Vest 6,286,000   6,286,000  
Exercisable 4,314,000   4,314,000  
Aggregate intrinsic value     2,900,000 4,100,000
Nonvested Stock [Abstract]        
Award vesting period (in years)     4 years  
Nonvested Stock, Weighted Average Grant Date Fair Value [Roll Forward]        
Ending Balance (in dollars per share)   $ 8.69   $ 8.69
Performance Shares [Abstract]        
Weighted Average Grant Date Fair Value per Share (in dollars per share)   $ 8.69   $ 8.69
Stock Options and SARs [Member] | Minimum [Member]
       
Significant weighted average assumptions [Abstract]        
Expected dividend yield (in hundredths)       1.60%
Stock Options and SARs [Member] | Maximum [Member]
       
Significant weighted average assumptions [Abstract]        
Expected dividend yield (in hundredths)       1.90%
Non-vested Stock Options And SARs [Member]
       
Nonvested Stock Option Awards and SARs, Outstanding [Roll Forward]        
Non-vested (in shares)     1,794,350  
Vested (in shares)     (627,711)  
Forfeited (in shares)     (305,625)  
Non-vested (in shares) 861,014   861,014  
Nonvested Stock Option Awards and SARs, Weighted Average Grant Date Fair Value [Abstract]        
Non-vested (in dollars per share)     $ 6.72  
Vested (in dollars per share)     $ 6.22  
Forfeited (in dollars per share)     $ 6.16  
Non-vested (in dollars per share) $ 7.28   $ 7.28  
Non-vested Stock Options [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total compensation expense 827,000 685,000 1,455,000 1,094,000
Stock Options and SARs [Abstract]        
Weighted average grant date fair value $ 15.94   $ 15.94  
Nonvested Stock [Abstract]        
Nonvested stock conversion ratio     One for one  
Nonvested stock, outstanding [Roll Forward]        
Beginning Balance (in shares)     376,965  
Granted (in shares)     467,320  
Vested (in shares)     (130,038)  
Forfeited (in shares)     (63,573)  
Ending Balance (in shares) 650,674   650,674  
Nonvested Stock, Weighted Average Grant Date Fair Value [Roll Forward]        
Beginning Balance (in dollars per share)     $ 16.68  
Granted (in dollars per share)     $ 15.84  
Vested (in dollars per share)     $ 16.27  
Forfeited (in dollars per share)     $ 18.91  
Ending Balance (in dollars per share) $ 15.94   $ 15.94  
Aggregate intrinsic value     2,100,000  
Number of shares issued (in shares)     115,406  
Performance Shares [Abstract]        
Target Shares Granted (in shares)     467,320  
Target Shares Forfeited (in shares)     (63,573)  
Target Shares Outstanding (in shares) 650,674   650,674  
Weighted Average Grant Date Fair Value per Share (in dollars per share) $ 15.94   $ 15.94  
Number of shares vested (in shares)     (130,038)  
Aggregate intrinsic value     2,100,000  
Number of shares issued (in shares)     115,406  
Non-vested Stock Options [Member] | Minimum [Member]
       
Stock Options and SARs [Abstract]        
Award vesting period (in years)     1 year  
Nonvested Stock [Abstract]        
Award vesting period (in years)     1 year  
Non-vested Stock Options [Member] | Maximum [Member]
       
Stock Options and SARs [Abstract]        
Award vesting period (in years)     4 years  
Nonvested Stock [Abstract]        
Award vesting period (in years)     4 years  
Performance Shares [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Total compensation expense 611,000 515,000 441,000 862,000
Nonvested stock, outstanding [Roll Forward]        
Beginning Balance (in shares)     171,225  
Granted (in shares)     243,100  
Forfeited (in shares)     (47,500)  
Ending Balance (in shares) 366,825   366,825  
Performance Shares [Abstract]        
Number of shares issuable, minimum (in shares)     0  
Multiple of the number of granted shares outstanding for issuable shares     2  
Performance cycle (in years)     3 years  
Target Shares Granted (in shares)     243,100  
Target Shares Forfeited (in shares)     (47,500)  
Target Shares Outstanding (in shares) 366,825   366,825  
Stock Options [Member]
       
Stock Options and SARs [Abstract]        
Award expiration period (in years)     10Y  
Performance Share Grant 2009 [Member]
       
Nonvested stock, outstanding [Roll Forward]        
Vested (in shares)     40,314  
Nonvested Stock, Weighted Average Grant Date Fair Value [Roll Forward]        
Aggregate intrinsic value     700,000  
Number of shares issued (in shares)     29,650  
Performance Shares [Abstract]        
Number of shares vested (in shares)     40,314  
Aggregate intrinsic value     700,000  
Number of shares issued (in shares)     29,650  
Tax liability paid by recipient of award $ 200,000   $ 200,000  
Performance Share Grant 2010 [Member]
       
Stock Options and SARs [Abstract]        
Weighted average grant date fair value $ 19.75   $ 19.75  
Nonvested stock, outstanding [Roll Forward]        
Beginning Balance (in shares)     107,000  
Granted (in shares)     0  
Forfeited (in shares)     (25,000)  
Ending Balance (in shares) 82,000   82,000  
Nonvested Stock, Weighted Average Grant Date Fair Value [Roll Forward]        
Ending Balance (in dollars per share) $ 19.75   $ 19.75  
Performance Shares [Abstract]        
Target Shares Granted (in shares)     0  
Target Shares Forfeited (in shares)     (25,000)  
Target Shares Outstanding (in shares) 82,000   82,000  
Weighted Average Grant Date Fair Value per Share (in dollars per share) $ 19.75   $ 19.75  
Performance Share Grant 2011 [Member]
       
Stock Options and SARs [Abstract]        
Weighted average grant date fair value $ 25.00   $ 25.00  
Nonvested stock, outstanding [Roll Forward]        
Beginning Balance (in shares)     64,225  
Granted (in shares)     0  
Forfeited (in shares)     (22,500)  
Ending Balance (in shares) 41,725   41,725  
Nonvested Stock, Weighted Average Grant Date Fair Value [Roll Forward]        
Ending Balance (in dollars per share) $ 25.00   $ 25.00  
Performance Shares [Abstract]        
Target Shares Granted (in shares)     0  
Target Shares Forfeited (in shares)     (22,500)  
Target Shares Outstanding (in shares) 41,725   41,725  
Weighted Average Grant Date Fair Value per Share (in dollars per share) $ 25.00   $ 25.00  
Performance Share Grant 2012 [Member]
       
Stock Options and SARs [Abstract]        
Weighted average grant date fair value $ 18.04   $ 18.04  
Nonvested stock, outstanding [Roll Forward]        
Beginning Balance (in shares)     0  
Granted (in shares)     243,100  
Forfeited (in shares)     0  
Ending Balance (in shares) 243,100   243,100  
Nonvested Stock, Weighted Average Grant Date Fair Value [Roll Forward]        
Ending Balance (in dollars per share) $ 18.04   $ 18.04  
Performance Shares [Abstract]        
Target Shares Granted (in shares)     243,100  
Target Shares Forfeited (in shares)     0  
Target Shares Outstanding (in shares) 243,100   243,100  
Weighted Average Grant Date Fair Value per Share (in dollars per share) $ 18.04   $ 18.04  
2001 Equity Incentive Plan [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares reserved for issuance upon exercise of awards 12,375,000   12,375,000  
2008 Equity Incentive Plan [Member]
       
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares reserved for issuance upon exercise of awards 4,550,000   4,550,000